As one of the fastest growing classes of medications, GLP-1 weight-loss drugs were originally brought on the market to treat diabetes
FeelGood GLP-1 2026 Research Explores Brand-Stated $149/Month Telehealth Access, Compounded Medication Disclosures, and Buyer Questions Why This Review Exists Right Now - and Why Timing Matters for GLP-1 Buyers in 2026 FDA has publicly identified concerns involving unapproved and compounded GLP-1 products, including dosing errors, improper storage during shipping, fraudulent compounded products, adverse-event reports, semaglutide salt forms, and illegal online sales
Inactivation mechanism of N61S mutant of human FMO3 towards trimethylamine
Magnetic resonance spectroscopy study of the antioxidant defense system in schizophrenia
Importantly, several drugs have been developed to treat type 2 diabetes that re-sensitize insulin receptors and may be of use to prevent neurodegenerative processes
Costantini A, Pala MI, Grossi E, et al